Category: Pharmaceutical

Sales of Behavioural Health Treatment Market to Grow at a CAGR of 2.4% Through 2027

Post author By administrator
Post date October 25, 2021
No Comments on Sales of Behavioural Health Treatment Market to Grow at a CAGR of 2.4% Through 2027

Burden of mental illness on Europe’s economy is among the largest in the world, inadvertently making it the most lucrative region for players in the behavioural health treatment market, with the region slated to account for a staggering 47% of the global market by 2027. Total cost associated with mental health treatment amounted to around US$ 668 Bn in 2018 across the EU, translating to 4% of the GDP of Europe. Taking cue from this opportunity, key players are striving to expand their treatment facilities to offer easy accessibility to patients.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=4370

However, uneven distribution of therapy facilities and rehabilitation centres in rural regions across the globe is projected to result in sluggish growth of the behavioural health treatment market, with an estimated CAGR of 2.4% during the forecast period (2020-2027).

Key Takeaways of Behavioural Health Treatment Market Study

According to WHO, 800,000 suicides are recorded every year, on the back of depression and anxiety disorders. Symptoms of depression are found to be high among millennial cohort as compared to other age groups, influenced by reckless use of social media and stressful lifestyles. Revenue generation through patient base suffering from depression is projected to grow by 3.2% in 2027 over 2026.
- Individuals will continue to show a high interest in outpatient counselling services, as these programs offer freedom of movement over inpatient hospital treatment services. Given the high relevance of this influence, outpatient counselling services are projected to witness a marginal rise, at a CAGR of around 2.7% during the forecast period.
- Social stigma associated with mental health discourages individuals from seeking proper treatment and counselling, which could hinder behavioural health treatment market growth during the forecast period.

Asia Pacific is projected to record the highest growth rate of nearly 2.8% during 2020-2027, which is attributable to increase in service centres and debunking of mental health taboos through awareness campaigns by various government and non-governmental organizations.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4370

A senior analyst at Fact.MR opines, “Advent of on-demand service model will remain crucial for the behavioural health treatment market, especially in developing regions, on account of high social stigma related to opting for mental health therapy. Additionally, value-based subscription models offered by on-demand counselling would be easy on the pockets of patients, which is projected to drive a massive shift from hospital and outpatient-based care to home-based care.”

Leading Players Intensify Focus on Expansion of Inpatient Care Facility

Although the behavioural health treatment market boasts of a number of organized players, numerous individual practitioners operating at regional and local levels generate a significant chunk of revenue. Lack of stringent regulations for practicing behavioural health services reduces the entry barrier in the market, and further adds a layer of fragmentation to the behavioural health treatment market.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/4370

Key focus of players to strengthen their foothold in the behavioural health treatment market remains on the expansion of inpatient care facilities. For instance, in January 2019, Acadia Healthcare announced the acquisition of Whittier Pavilion, which is an inpatient psychiatric facility with 71 beds. In May 2019, MercyOne Central Iowa and Universal Health Services, Inc. established a new facility at Iowa, with 100 beds, to offer high quality services for behavioural health.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

ENT Cameras Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2281/ent-cameras-market

Automated Dialysis Concentrated Production Systems Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2280/automated-dialysis-concentrated-production-systems-market

Oral & Topical Anaesthetics Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2279/oral-topical-anaesthetics-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Tags Behavioural Health Treatment Market, Behavioural Health Treatment Market Analysis, Behavioural Health Treatment Market Demand, Behavioural Health Treatment Market Estimate, Behavioural Health Treatment Market Forecast, Behavioural Health Treatment Market Insights, Behavioural Health Treatment Market Scope, Behavioural Health Treatment Market Share, Behavioural Health Treatment Market Size, Behavioural Health Treatment Market Statistics, Behavioural Health Treatment Market Trends

Pharmaceutical

Demand for Animal Genetics Market to Grow at a CAGR of 6% Through 2026

Post author By administrator
Post date October 25, 2021
No Comments on Demand for Animal Genetics Market to Grow at a CAGR of 6% Through 2026

Recent advancements in genomic technology are extending the frontiers of innovation in livestock production. Easy availability of molecular tools and enzymes, such as Digital Polymerase Chain Reaction (dPCR), to extract vital information about livestock species, is increasing the possibilities to develop embryos of desired gender and traits.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=4323

The livestock revolution trend is found to complement the growth of the food industry. Given the shift from conventional protein sources to animal-derived proteins, lucrative opportunities await players in the animal genetics market to meet the unmet nutrition demand of humans. Growth opportunities are also projected to arrive from the growing significance of pet culture, especially found in developed regions, and gradually moving towards the developing ones. The quest for best-of-breed livestock animals will increase reliance on animal genetics to produce attractive animals, and, in turn, improve the probabilities of pet adoption.

Recalibrating the relevance of these trends, analysts at Fact.MR maintain an optimistic outlook of the animal genetics market growth, with an anticipated CAGR of ~6% during the forecast period (2020-2026).

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4323

Animal Genetics Market – Assessment of Segmentation

The global animal genetics market is segmented based on product and geography.

Product	Live Animals Bovine Porcine Poultry Canine Piscine Others Genetic Material Semen Embryo Others Genetic Testing
Geography	North America US Canada Europe UK Germany France Spain Italy Rest of Europe Asia Pacific Australia and New Zealand Japan China India Rest of APAC

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/4323

Numerous players are involved in the advancement of genetics by collaborating with independent laboratories or by entering into license agreements to leverage technology to develop better breeds. For instance, in January 2019, Neogen Corporation, a prominent player in the global animal genetics market, acquired the Canadian animal genomics laboratory – Delta Genomics Centre – in an attempt to strengthen its hold in the North American market, especially in Canada. Another key player, Genus IntelliGen Technologies, announced the transfer of its sexed genetics technology to Geno, a leading producer of bovine genetics in Norway. This transaction will enable Geno to develop sexed Norwegian Red genetics.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

ENT Cameras Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2281/ent-cameras-market

Oral & Topical Anaesthetics Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2279/oral-topical-anaesthetics-market

About Us:

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Tags Animal Genetics Market, Animal Genetics Market Analysis, Animal Genetics Market Demand, Animal Genetics Market Estimate, Animal Genetics Market Forecast, Animal Genetics Market insights, Animal Genetics Market scope, Animal Genetics Market Share, Animal Genetics Market Size, Animal Genetics Market Statistics, Animal Genetics Market Trends

Pharmaceutical

Which Regions Could be Highly Beneficial for Patient Positioning System Providers

Post author By administrator
Post date October 25, 2021
No Comments on Which Regions Could be Highly Beneficial for Patient Positioning System Providers

Patient’s dignity and comfort are of paramount importance in the field of medical surgery. Nurses are properly trained on patient positioning principles, and hospitals are also compelled to be equipped with leading products that can facilitate effective patient positioning.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=52

The Fact.MR forecast report on global patient positioning market projects that the market will reach US$ 1.4 Bn value by the end of 2017. With improving healthcare infrastructures and adoption of ergonomic designs, manufacturers of patient positioning products are likely to boost their capacity in the years to come.

Towards the end of 2022, the global market for patient positioning will have expanded steadily at 6.1% CAGR, raking revenues worth slightly over US$ 1.9 Bn.

Key Forecast Highlights

According to the report, tables will account for nearly 20% share on global patient positioning revenues in 2017. Surgical tables, on the other hand, will be observed as top-selling products in the global patient positioning market. By the end of 2022, nearly US$ 500 Mn worth of revenues will be procured from sales of patient positioning surgical tables around the world.
Increasing emphasis on improving the healthcare infrastructure has propelled the adoption of patient positioning solutions in developing regions. Manufacturers of patient positioning are also viewing regions such as the Asia-Pacific excluding Japan (APEJ) region lucrative for setting up manufacturing units. High resource availability, low wage costs, coupled with dense population that translates into maximum end-use, are driving the growth of patient positioning market in the APEJ region. The report projects that the APEJ patient positioning market will soar vigorously at 7.2% CAGR, bringing in revenues worth over US$ 238 Mn by the end of 2022.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=52

North America is expected to remain the largest market for patient positioning. The report predicts that high healthcare spending in the US and Canada will prompt manufacturers in providing top-of-line products in the field of patient positioning. While revenues amassed from sales of patient positioning products in Europe will contribute to 30% of global market value, it is estimated North America’s patient positioning market will procure nearly US$ 480 Mn revenue towards the end of 2017.

Market Taxonomy

By Product	Tables Surgical Tables Radiolucent Imaging Tables Examination Tables Accessories Other Patient Positioning Systems
By End User	Hospitals Ambulatory Surgical Centers Diagnostic Centers

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/52

Hill-Rom, Inc., Stryker Corporation, Span-America Medical Systems, Inc., STERIS plc, Elekta AB(publ), Skytron, C-RAD, LEONI AG, and Mizuho OSI are key companies profiled in the report as leading players in the global patient positioning market.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

ENT Cameras Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2281/ent-cameras-market

Oral & Topical Anaesthetics Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2279/oral-topical-anaesthetics-market

About Us:

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Tags Patient Positioning System Market, Patient Positioning System Market Analysis, Patient Positioning System Market Demand, Patient Positioning System Market Estimate, Patient Positioning System Market Forecast, Patient Positioning System Market Insights, Patient Positioning System Market Scope, Patient Positioning System Market Share, Patient Positioning System Market Size, Patient Positioning System Market Statistics, Patient Positioning System Market Trends

Pharmaceutical

North America’s Anesthesia Machines Market to Expand at a CAGR of 5.6% Through 2022

Post author By administrator
Post date October 25, 2021
No Comments on North America’s Anesthesia Machines Market to Expand at a CAGR of 5.6% Through 2022

A recent study conducted by Fact.MR reveals that the global market for anesthesia machines is set to reflect a CAGR of 5.4% between 2017 and 2022. Increasing medical tourism, an augmenting number of surgical procedures and rising healthcare spending are some of the primary factors expected to remain instrumental to the growth of the market.

For detailed insights on enhancing your product footprint, request for a sample here- https://www.factmr.com/connectus/sample?flag=S&rep_id=96

Today, anesthesia machines are being increasingly incorporated in healthcare systems as they are seen as a key medical apparatus. These machines are also proving to be extremely helpful in ambulatory units and nursing homes. Mostly, professionals with expertise or sufficient knowledge of anesthesiology are certified to operate and handle anesthesia machines.

The advance version of the machines offer higher patient convenience and safety. Anesthesia machine and the technology behind it has constantly evolved over the years. The machines used today, are completely different from the conventional versions that were based on pneumatic systems. With the rise in the global population, the occurrences of invasive surgeries have also escalated.

Factor as such are expected to support the growth of the global anesthesia machines market in years to come. In addition, innovation in technology is encouraging its adoption in the healthcare sector as they become more effective. Most anesthesia machines currently come with leading-edge continuous-flow anaesthetic system that is designed to regulate a precise and continuous supply of anesthetic gases to the patient. The contemporary machines are incorporated with suction unit, patient monitoring devices, and ventilators.

For critical insights on this market, request for methodology here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=96

Following takeaways from Fact.MR’s Forecast on the global market for anesthesia machines will play a significant role in market’s future development

Increase occurrence of chronic ailments such as cancer, high cholesterol and diabetes coupled with the expanding pool of the geriatric population is projected to propel the overall growth of the market.
The anesthesia machines market in North America currently accounts for the global market. In addition, North America is expected to remain one of the most attractive market for anesthesia machines over 2022 and reflect a CAGR of over 5%. This is owing to rapid adoption of cutting-edge medical care technologies in the region.
Demand for anesthetic machines in Asia Pacific excluding Japan (APEJ) is also projected to surge at a significant rate during the forecast period. Growing disposable income and rising healthcare awareness among consumers is playing a crucial role in adoption of the anesthesia machines in the hospitals and clinics in the region.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/96

Based on modality, the standalone segment currently commands for close to 56% market share in terms of revenue. Towards the end of 2022, this segment is estimated to reach a market valuation in excess of US$ 7,081 Mn. Meanwhile, the portable segment is also likely to witness an impressive CAGR between 2017 and 2022.

Competition Tracking

General Electric Company, Spacelabs Healthcare, Shenzhen Comen Medical Instruments Co. Ltd., DRE Medical, Midmark Corporation, Heyer Medical AG, Infinium Medical Inc, Koninklijke Philips N.V., Dragerwerk AG, Shenzhen Comen Medical Instruments Co. Ltd., and Dameca A/S. are among the prominent companies mentioned in the report.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Ultrasound Systems Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031:https://www.factmr.com/report/60/ultrasound-systems-market

Blood Thawing System Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031: https://www.factmr.com/report/blood-thawing-system-market

Radiation Proctitis Treatment Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031: https://www.factmr.com/report/5281/radiation-proctitis-treatment-market

About Us:

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Tags Anesthesia Machines Market, Anesthesia Machines Market Analysis, Anesthesia Machines Market Demand, Anesthesia Machines Market Estimate, Anesthesia Machines Market forecast, Anesthesia Machines Market insights, Anesthesia Machines Market Scope, Anesthesia Machines Market Share, Anesthesia Machines Market size, Anesthesia Machines Market Statistics, Anesthesia Machines Market trends

Pharmaceutical

Increasing Healthcare Expenditure to Boost Sales of Medical Marker Bands Through 2029

Post author By administrator
Post date October 25, 2021
No Comments on Increasing Healthcare Expenditure to Boost Sales of Medical Marker Bands Through 2029

Radiopacity of medical marker bands is giving significant impetus to their demand in the medical marker bands market. The properties of medical marker bands that increases their visibility under fluoroscopes or x-ray during critical procedures is giving an uptick to their sales worldwide.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=4364

Manufacturers of medical marker bands are also showing a marked preference for cost-effective materials such as polymer and tantalum instead of traditional gold, platinum and palladium. On the back of these factors, Fact.MR- a well-established name in the market research domain-forecasts that the global medical marker bands market will experience a major upsurge, reaching a growth of ~ US$ 28 Mn by 2029.

Key Takeaways of Medical Marker Bands Market

According to Fact.MR, growth of the medical marker bands market is expected to increase 1.7X during the forecast year owing to increased usage of medical marker bands in cardiovascular intervention procedures

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4364

High visibility under x-ray is expected to be the promising factor for increased use of medical marker bands in critical medical procedures
Feasibility of tracking catheter position in a complex endovascular procedure to avoid instrument and vessel collision is boosting the demand for medical marker bands

Acquisitions and Mergers Signify Growth in a Fragmented Market

The medical marker bands market is fragmented. Tier 1 players functioning in the medical marker bands market include Merit Medical Systems, Inc., and Putnam Plastics. Both companies have a high market share owing to their brand recognition and global reach.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/4364

Dearth of advanced manufacturing facilities coupled with a large aging workforce and skills gap in countries such as India and China are encouraging export of medical marker bands from other countries such as the U.S., Germany, the U.K., etc. To overcome these issues, key players are focusing on increasing their reach through acquisitions and mergers. For instance:
In August 2019, Biomerics merged with Northeast Laser & Electropolish, a contract manufacturer providing services to a wide range of medical device manufacturers. This merger formed Biomerics NLE, a metal division of Biomerics that provide full-service metal processing to the interventional and surgical medical device industry.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Ultrasound Systems Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031:https://www.factmr.com/report/60/ultrasound-systems-market

Blood Thawing System Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031: https://www.factmr.com/report/blood-thawing-system-market

Radiation Proctitis Treatment Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031: https://www.factmr.com/report/5281/radiation-proctitis-treatment-market

About Us:

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Tags Medical Marker Bands Market, Medical Marker Bands Market Analysis, Medical Marker Bands Market Demand, Medical Marker Bands Market Estimate, Medical Marker Bands Market Forecast, Medical Marker Bands Market Insights, Medical Marker Bands Market Scope, Medical Marker Bands Market Share, Medical Marker Bands Market Size, Medical Marker Bands Market Statistics, Medical Marker Bands Market Trends

Pharmaceutical

Demand for Sterile Active Pharmaceutical Ingredient Market to Exhibit 6.7% CAGR through 2029

Post author By administrator
Post date October 25, 2021
No Comments on Demand for Sterile Active Pharmaceutical Ingredient Market to Exhibit 6.7% CAGR through 2029

Companies in the Sterile Active Pharmaceutical Ingredients Market are facing issues in keeping their production facilities fully functional due to shortage of staff and resources amidst the COVID-19 (Coronavirus) outbreak. Get a hands-on over key drivers and threats to the Sterile Active Pharmaceutical Ingredients Market to make your company future-ready post the pandemic. Avails out reports for exciting prices to learn new opportunities that companies can capitalize on during and after the Coronavirus crisis.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=1702

Rising acceptance of biologics and preventive medicines is expected to propel the demand for sterile active pharmaceutical ingredients. Significant accessibility to drugs, growing pharmaceutical spending, and rising demand for targeted therapy drugs are factors boosting sterile active pharmaceutical ingredients market growth. China and India are the prominent suppliers of sterile active pharmaceutical ingredients, globally.

Manufacturers are focusing on the expansion of their manufacturing plants in these countries owing to low-cost production and cheap labor. On this premise, global sterile active pharmaceutical ingredients market was valued at US$53 Bn in 2018 and will witness dexterous growth through 2029.

Key Takeaways of Sterile Active Pharmaceutical Ingredients Market Study

By product type, monoclonal antibodies accounted for prominent market value share in the sterile active pharmaceutical ingredients market. This is primarily attributed to growing need for biologics and targeted therapies for treatment of chronic disorders such as cancer.South Asia and East Asia collectively hold over 33% of the sterile active pharmaceutical ingredients market share owing to expansion of sterile active pharmaceutical ingredients manufacturing facilities for small API molecules in these regions.Aqueous form is expected to be the dominant segment in the sterile active pharmaceutical ingredients market attributed to the ability to provide great solubility for non-water-soluble drugs.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=1702

“Increasing investments for sterile fill-finish capabilities expansion and inclination towards in-house sterile API production as a cost reduction strategy by pharmaceutical manufacturers are anticipated to favor the global sterile active pharmaceutical ingredients market growth.” says the Fact.MR Analyst.

Emphasis on Manufacturing Capability, Key Strategy Followed by Market Players

Sterile active pharmaceutical ingredients manufacturers are focusing on the expansion of manufacturing facilities and adopting advanced aseptic processing techniques. For instance, in October 2017, Corden Pharma GmbH announced a strategic investment of US$ 4 million in small molecule API development capacity in its Corden Pharma Switzerland facility.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/1702

With growing investments for infrastructural and technological advancements, manufacturers are also focusing on the opening up of new production plants for sterile active pharmaceutical ingredients in emerging countries. For instance, in October 2018, Sun Pharmaceutical Industries Ltd. opened a new cGMP production line in Guwahati, India to enhance the manufacturing capacity of sterile products.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Ultrasound Systems Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031:https://www.factmr.com/report/60/ultrasound-systems-market

Blood Thawing System Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031: https://www.factmr.com/report/blood-thawing-system-market

Radiation Proctitis Treatment Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031: https://www.factmr.com/report/5281/radiation-proctitis-treatment-market

About Us:

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Tags Sterile Active Pharmaceutical Ingredient Market, Sterile Active Pharmaceutical Ingredient Market Analysis, Sterile Active Pharmaceutical Ingredient Market Demand, Sterile Active Pharmaceutical Ingredient Market Estimate, Sterile Active Pharmaceutical Ingredient Market Forecast, Sterile Active Pharmaceutical Ingredient Market Insights, Sterile Active Pharmaceutical Ingredient Market Scope, Sterile Active Pharmaceutical Ingredient Market Share, Sterile Active Pharmaceutical Ingredient Market Size, Sterile Active Pharmaceutical Ingredient Market Statistics, Sterile Active Pharmaceutical Ingredient Market Trends

Pharmaceutical

Global Glass Dual Chamber Prefilled Syringes Market to Exceed US$ 2,000 Mn in Revenues by 2026-end

Post author By administrator
Post date October 25, 2021
No Comments on Global Glass Dual Chamber Prefilled Syringes Market to Exceed US$ 2,000 Mn in Revenues by 2026-end

The ever-evolving Coronavirus (COVID-19) has caused interruptions in supply chains of companies in the Dual Chamber Prefilled Syringes Market. Through careful analysis of the COVID-19, our analysts at Fact.MR offer you a bird’s eye view of the current on goings of top tier companies in the Dual Chamber Prefilled Syringes Market. Learn how leading companies are striking potential partnership agreements to generate sales in the Dual Chamber Prefilled Syringes Market.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=486

According to Fact.MR’s recently collated research report, a spectacular growth has been envisaged for the global Dual Chamber Prefilled Syringes Market in the forecast period (2017-2026). Worldwide sales of dual chamber prefilled syringes are poised to bring in approximately US$ 3,300 Mn revenues by 2026-end.

Dual Chamber Prefilled Syringes – Efficient Solution for Reconstituting Lyophilized Drugs during Administration

There has been an incessant requirement for reconstituting the lyophilized drugs during their administration, along with growing necessity of tackling potential compliance and safety issues associated with the reconstitution. This has further led to the development of syringes that are capable of curtailing number of steps required for the reconstitution of drugs and making them available for injection.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=486

Lyophilized drugs have represented a robust penetration worldwide in the recent past. Lyophilized drugs account for largest share of all reconstitution-requiring injectable/infusible drugs. As a large number of injectable/infusible drugs have been developed for self-administration, special challenges are incurred for the drug developers. However, dual chamber prefilled syringes, which are particularly designed for simplifying reconstitution devoid of patient handling of diluent or drug, have become the mainstay option for delivering these drugs, meanwhile curtailing challenges faced by developers.

With lyophilized drugs witnessing proliferated penetration, demand for dual chamber prefilled syringes will gain a significant upsurge in the foreseeable future.

5 Key Takeaways from Fact.MR’s Report on Dual Chamber Prefilled Syringes Market for Forecast Period 2017-2026

Sales of dual chamber prefilled syringes are expected to record the fastest expansion in online pharmacies through 2026, trailed by retail pharmacies that will account for a relatively larger market revenue share than online pharmacies by 2026-end.
In terms of revenues, hospital pharmacies will continue to be the leading contributor to the global dual chamber prefilled syringes market.
Based on product material, glass prefilled syringes are anticipated to remain sought-after in the market, with sales projected to exceed US$ 2,000 Mn in revenues by 2026-end. Plastic prefilled syringes will exhibit a relatively higher CAGR in the market through 2026.
On the basis of product type, conventional prefilled syringes are expected to account for the lion’s share of the market during 2017 to 2026. Safety prefilled syringes will account for nearly 30% revenue share of the market through the forecast period.
North America is likely to prevail as the fast-expanding as well as the most lucrative market for dual chamber prefilled syringes, followed by Europe. Asia-Pacific excluding Japan (APEJ) will also account for a major chunk of the market’s revenue share during the forecast period.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/486

With trends of surging demand for self-injection syringes, and the development of advanced dual chamber prefilled syringes, major players in the market have directed their concentration toward product portfolio expansion. In this rapidly evolving and highly competitive market, several players are emphasizing on essentiality of the up-to-date information, in a bid to monitor their performance and make critical decisions apropos to profitability & growth. Few market players are also focusing on improvements in design of the dual chamber prefilled syringes in order to enhance the stability as well as safety of various sensitive drugs. Key players actively underpinning the market growth, as profiled by Fact.MR’s report, include Pfizer Inc., Amgen Inc., Boehringer Ingelheim GmbH, Nipro Corporation, Vetter Pharma-Fertigung GmbH & Co. KG, Gerresheimer AG, Ypsomed Holding AG, West Pharmaceutical Services, Inc., Schott AG, Otsuka America Pharmaceutical, Inc., Credence MedSystems, Inc., Catalent, Inc., and Bespak Europe Ltd.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Neuro Ablation Devices Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2283/neuro-ablation-devices-market

Neuralgia Treatment Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2282/neuralgia-treatment-market

ENT Cameras Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2281/ent-cameras-market

About Us:

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Tags Dual Chamber Prefilled Syringes Market, Dual Chamber Prefilled Syringes Market analysis, Dual Chamber Prefilled Syringes Market Demand, Dual Chamber Prefilled Syringes Market Estimate, Dual Chamber Prefilled Syringes Market Forecast, Dual Chamber Prefilled Syringes Market Insights, Dual Chamber Prefilled Syringes Market Scope, Dual Chamber Prefilled Syringes Market share, Dual Chamber Prefilled Syringes Market size, Dual Chamber Prefilled Syringes Market Statistics, Dual Chamber Prefilled Syringes Market trends

Pharmaceutical

North America to Lead the Global Respiratory Virus Vaccines Market Through 2030

Post author By administrator
Post date October 25, 2021
No Comments on North America to Lead the Global Respiratory Virus Vaccines Market Through 2030

Incessantly rising demand in response to the unbridled spread of COVID-19 has pushed the respiratory virus vaccines market to the fore. Fact MR’s recent study on the market is intended to offer insights into the future and discover hidden opportunities for market players. Increasing R&D investments and initiatives are aiding exponential growth in the market.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=5199

Considering that the aforementioned trend will show no signs of slowing down, Fact.MR projects the market to rise at an 8% CAGR from 2020 and 2030. With some prominent international organizations increasing their funding towards research & development, the market is expected to gain significant impetus over the coming years. For instance, the National Institute of Allergy and Infectious Diseases (NIAID) has recently announced a funding of US$ 51 Mn towards the Collaborative Influenza Vaccine Innovation Centers (CIVICs) program, with the intention of developing influenza vaccines.

Key Takeaways from Respiratory Virus Vaccines Market Study

The global respiratory virus vaccines market is expected to surpass a valuation of US$ 14 Bn by 2030.
North America currently dominates the global market for respiratory virus vaccines.
Based on type, inactivated/ killed vaccines’ hegemony will continue through 2030.
Based on indication, demand from the influenza segment will remain comparatively higher.
Among all the age groups, demand from the pediatric segment is likely to be higher.
Physician offices are currently dominating among the end users.

“Demand witnessed in the respiratory virus vaccines market is forecast to surge especially on account of the unprecedented outbreak of COVID-19. An increasing number of market players are expected to focus on research initiatives, to gain a competitive advantage in this space,” says a Fact.MR analyst.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=5199

Respiratory Virus Vaccines Market: Segmentation

Fact.MR has studied the respiratory virus vaccines market with detailed segmentation on the basis of type, route of administration, indication, age group, end user, and key regions.

Type

Route of Administration

Indication

Age Group

End User

Region

Inactivated/Killed Vaccines
Live-attenuated Vaccines
Recombinant Vaccines

Intramuscular
Intranasal
Subcutaneous

Influenza
Measles, Mumps & Rubella
Coronavirus Disease (COVID-19)
Others

Pediatric
Adults

Physician Offices
Hospitals
Clinics
Pharmacies/Stores

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/5199

Rising Burden of Respiratory Illnesses Fuelling Demand

According to the World Health Organization, nearly 290,000 to 650,000 people die every year around the world due to flu-related illnesses. Rising incidence of respiratory illnesses and subsequently increasing demand for vaccines to prevent respiratory infections are the chief drivers of the global market.

With leading pharmaceutical companies racing to be the first to develop and launch a vaccine for the novel coronavirus, the respiratory virus vaccines market is expected to surge exponentially through the course of the forecast period.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Neuro Ablation Devices Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2283/neuro-ablation-devices-market

Neuralgia Treatment Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2282/neuralgia-treatment-market

ENT Cameras Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2281/ent-cameras-market

About Us:

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Tags Respiratory Virus Vaccines Market, Respiratory Virus Vaccines Market Analysis, Respiratory Virus Vaccines Market Demand, Respiratory Virus Vaccines Market Estimate, Respiratory Virus Vaccines Market forecast, Respiratory Virus Vaccines Market Insights, Respiratory Virus Vaccines Market Scope, Respiratory Virus Vaccines Market Share, Respiratory Virus Vaccines Market size, Respiratory Virus Vaccines Market Statistics, Respiratory Virus Vaccines Market trends

Pharmaceutical

Sales of Audiometers to Reach US$ 685 Mn Revenues by 2026

Post author By administrator
Post date October 25, 2021
No Comments on Sales of Audiometers to Reach US$ 685 Mn Revenues by 2026

A recent study published by Fact.MR shows a marked rise in the adoption of hearing aids, which is projected to grow in excess of US$ 8 Bn by 2026, as individuals are evincing high interest towards high-tech devices to treat hearing loss. Availability of a wide range of hearing aids further offers choices to select the right audiological device, which is resonating well with individuals suffering from poor hearing conditions.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=4444

Receiver-in-the-ear is the most preferred hearing aid, and is expected to witness a CAGR of around 5.1% during the forecast period (2020-2026), on account of its lightweight and easy accessibility. However, hearing aids may not be effective among individuals with severe hearing loss, which is likely to fuel the adoption rate of cochlear implants during the forecast period.

Key Highlight of Audiological Devices Market Study

Patients in developed regions, and in developing regions to some extent, are increasingly becoming conscious of their health issues, which is encouraging them to undergo diagnosis and avail quality care. This continues to gain significance to diagnostic devices in the audiological devices market.
Demand for audiometers is high in hospitals and clinics to measure the hearing levels of patients. On the back of high adoption, audiometers are likely to record sales tantamount to US$ 685 Mn by 2026.
Increasing sales of audiological devices are highly attributable to the growing prevalence of Meniere’s disease. Also, the study finds that, a larger pool of women is affected by this disease as compared to men. Adoption of audiological devices among patients suffering from the disease is projected to grow to 33% by 2026.
Hospitals are gradually losing prominence in the audiological devices market to clinics, owing to long-wait windows and high treatment costs associated with the former. Clinics are expected to account for nearly 50% of the audiological devices market by 2026.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4444

Audiological Devices Market Segmentation

Fact.MR has studied the audiological devices market with detailed segmentation on the basis product, disease type, end-user and key regions.

Product	Hearing Aids: In-the-ear Hearing Aids (ITE) Receiver-in-the-ear Hearing Aids (RITE) Behind-the-ear Hearing Aids (BTE) Canal Hearing Aids (CHA) Cochlear Implants Bone-anchored Healing Aids
Disease Type	Otosclerosis Meniere’s Disease Acoustic Tumors Otitis Media Others
End-user	Hospitals Ambulatory Surgical Centers Clinics

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/4444

Product Innovation – A Key Strategy Adopted by Players across All Tiers

Key parameters forming the basis of competition in the audiological devices market include distribution partnerships, pricing, and product differentiation. Leading players—Medtronic, William Demant, Sonova, and Starkey Hearing Technologies—undertake intense research & development activities to stay ahead of the curve through product innovation.

The latest hearing aids are integrated with wireless technology that helps them connect to Android and iOS devices. Moreover, players in the audiological devices market continue to focus on the development of sleeker hearing aids to offer convenience to patients.

Expansion of product portfolio is the strategy adopted by players of all tiers. For instance, GN Store Nord A/S announced the launch of Interton Ready, which is built on 2.4 GHz connectivity that helps individuals listen to songs and use it for phone calls.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Neuro Ablation Devices Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2283/neuro-ablation-devices-market

Neuralgia Treatment Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2282/neuralgia-treatment-market

ENT Cameras Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2281/ent-cameras-market

About Us:

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Tags Audiological Devices Market, Audiological Devices Market Analysis, Audiological Devices Market Demand, Audiological Devices Market Estimate, Audiological Devices Market Forecast, Audiological Devices Market Insights, Audiological Devices Market Scope, Audiological Devices Market Share, Audiological Devices Market Size, Audiological Devices Market Statistics, Audiological Devices Market Trends

Pharmaceutical

Hemophilia Gene Therapy Market Sales Witness Incremental Dollar Opportunity During Forecast Period 2021- 2031

Post author By administrator
Post date October 24, 2021
No Comments on Hemophilia Gene Therapy Market Sales Witness Incremental Dollar Opportunity During Forecast Period 2021- 2031

According to Fact.MR, Insights of Hemophilia Gene therapy is a specialized and in-depth study of the industry with a special focus on the Key Trends of Hemophilia Gene therapy is a Service. The report aims to provide an overview with detailed segmentation by type, application, end use and geography. The global is expected to witness high growth during the forecast period.

A survey offers detailed analysis on key growth drivers of Hemophilia Gene therapy and trends accelerating Hemophilia Gene therapy sales globally. The survey also gives detailed analysis on the competitive landscape of, identifying key players and analyzing the impact of their growth strategies.

Request for a Brochure- https://www.factmr.com/connectus/sample?flag=B&rep_id=3107

Tentatively, Hemophilia Gene therapy Market has been segmented on the basis of product type.

On the basis of Indication, Hemophilia Gene therapy Market can be segmented as:

Hemophilia A
Hemophilia B

Global Hemophilia Gene therapy Market will witness advancement due to the rising population suffering from hemophilia. According to national institute of hemophilia approximately 20,000 people in U.S. and 400,000 worldwide are suffering from hemophilia. The National hemophilia foundation is awarding grants to further support the research for Hemophilia Gene therapy which will in turn help in the treatment of hemophilia. The biopharmaceutical manufacturers and research centers are working together to understand the genetics of hemophilia and improve Hemophilia Gene therapy which could help in treatment of hemophilia in the future.

Manufacturers such as Roche has recently acquired Spark Therapeutics for its long term investment hemophilia A gene therapy market. Also many drugs for hemophilia gene therapy are in clinical trials. The continuous investment and research by the manufacturers is expected to improve the hemophilia gene therapy market in the coming future. Also Hemophilia Gene therapy assures to address the unmet needs by one time administration which will further improve its severity. However the arrival of Hemophilia Gene therapy is a concern over its affordability and accessibility.

Geographically, global Hemophilia Gene therapy Market is split into regions viz. North America, Latin America, Middle East & Africa, Asia Pacific, Western Europe and Eastern Europe. North America’s Hemophilia Gene therapy Market is expected to grow because of evolution and progression in the technology and advancements to improve the patients’ health.

However the willingness of payers and government to arrange funding or insurance coverage for Hemophilia Gene therapy is not well established. If the manufacturers that bring Hemophilia Gene therapy to the market have conventional and older hemophilia therapies within their product portfolio their consideration to offer gene therapy for low price may lack as the new technology would disrupt their present market.

Request Customized Report as Per Your Requirements- https://www.factmr.com/connectus/sample?flag=RC&rep_id=3107

Some of the major market members in the Global Hemophilia Gene therapy Market identified across the value chain includes: F. Hoffmann-La Roche AG, Pfizer Inc., BioMarin Pharmaceuticals, uniQure, Shire PLC, Sangamo Therapeutics, among others.

Key Highlights:-

Sales of Hemophilia Gene therapy In 2020
Competitive Analysis Of Hemophilia Gene therapy
Demand Analysis Of Hemophilia Gene therapy
Key Trends Of Hemophilia Gene therapy
Supply Side Analysis Of Hemophilia Gene therapy
Outlook Of Hemophilia Gene therapy
Insights Of Hemophilia Gene therapy
Analysis Of Hemophilia Gene therapy
Survey Of Hemophilia Gene therapy
Size Of Hemophilia Gene therapy

A short viewpoint offered in the report elucidates the macro-economic aspects that influence the growth drivers of Hemophilia Gene therapy , which includes global GDP growth rate, various industries growth rate, such as cosmetics, pharmaceuticals, food and others.

This newly published and insightful report compounds sheds light on key dynamics, Key Trends of Hemophilia Gene therapy and their impact on the overall value chain from suppliers to end-users, which are expected to transform the future of the global Hemophilia Gene therapy sales.

Why choose Fact.MR?

We carry immense pride in saying that our work is recognized by 150+ countries worldwide. Our experience is conveyed by the fact that we have published 6, 000+ reports, thanks to our dedicated team of professionals. With digital intelligence solutions, we support our clients in remaining at the driver’s seat. Our crew of 300+ analysts are available 24/7 to offer dynamic updates regarding various verticals and companies.

Explore more reports on Healthcare Domain:

• Vaccinium myrtillus Market Forecast, Trend Analysis & Competition Tracking-Global Market Insights 2018 to 2028 – https://www.factmr.com/report/2081/vaccinium-myrtillus-market

• Hyperemesis Gravidarum Treatment Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028 –
https://www.factmr.com/report/2183/hyperemesis-gravidarum-treatment-market

• ENT Cameras Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028 – https://www.factmr.com/report/2281/ent-cameras-market

About Us:

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Tags Hemophilia Gene Therapy Market, Hemophilia Gene Therapy Market insight, Hemophilia Gene Therapy Market Share, Hemophilia Gene Therapy Market size, Hemophilia Gene Therapy Market Trends